In the relentless pursuit of patient safety and healthcare excellence, hospitals are continually exploring innovative solutions to enhance infection control measures. On November 27, 2023, at the Queen Elizabeth Hospital II Kota Kinabalu Sabah, a compelling presentation was delivered by Mr Gary Koh (Principle Speaker of Nay Lab Sdn Bhd) on the transformative benefits of UMONIUM38 High-Level Disinfectant within the hospital’s Central Sterile Services Department (CSSD) and Operation Theater (OT) department.
UMONIUM38, a cutting-edge high-level disinfectant, has emerged as a game-changer in the realm of hospital infection control. The presentation, attended by a total of 160 healthcare professionals, shed light on the profound impact of this disinfectant on maintaining the highest standards of sterilization and ensuring the safety of patients and healthcare operators.
Mr Gary Koh, an expert in infection control, began the session by delving into the unique features of UMONIUM38 that set it apart from conventional disinfectants. The patented pH-Neutral formulation’s efficacy against a broad spectrum of pathogens, including bacteria, viruses, spores, mycobacteria, yeast and fungi, was highlighted as a critical factor in its ability to elevate sterilization protocols.
The Central Sterile Services Department (CSSD), often referred to as the heart of hospital infection control, plays a pivotal role in ensuring that surgical instruments and medical equipment are meticulously sterilized before each use. Gary Koh emphasized how UMONIUM38 has streamlined and fortified the Central Sterile Services Department (CSSD)’s operations. Its rapid action and sustained effectiveness have significantly reduced the risk of nosocomial infections, ultimately contributing to improved patient outcomes.
In the context of the Operation Theater (OT), where precision and aseptic conditions are paramount, UMONIUM38’s impact is equally significant. The disinfectant’s ability to maintain a high level of microbial control on surfaces and equipment in the Operation Theater (OT) has resulted in a noticeable decline in surgical site infections. This not only enhances patient recovery but also optimizes the utilization of healthcare resources. Furthermore, Gary Koh elucidated the cost-effectiveness of UMONIUM38 in comparison to traditional disinfectants. The product’s longer-lasting effects translate into reduced frequency of applications, leading to cost savings for the hospital without compromising on the quality of infection control.
The engaging session concluded with a Q&A segment, where attendees had the opportunity to seek clarification and share their experiences with UMONIUM38. The overwhelming positive feedback and testimonials underscored the tangible benefits witnessed by healthcare professionals in the hospital’s Central Sterile Services Department (CSSD) and Operation Theater (OT) departments.
As hospitals globally grapple with the challenges of infection control, UMONIUM38 stands out as a beacon of innovation and reliability. The presentation by Gary Koh at Queen Elizabeth Hospital II served as a testament to the transformative power of this high-level disinfectant in fortifying the frontlines of healthcare, ultimately creating a safer environment for patients and healthcare operators alike.